Bill

Bill > A08130


NY A08130

NY A08130
Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.


summary

Introduced
10/13/2023
In Committee
01/03/2024
Crossed Over
Passed
Dead
12/31/2024

Introduced Session

2023-2024 General Assembly

Bill Summary

AN ACT to amend the public health law, in relation to the classification of the drug xylazine as a controlled substance; and to amend the penal law, in relation to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

AI Summary

This bill amends the New York Public Health Law to classify the drug xylazine as a Schedule I controlled substance. It also amends the New York Penal Law to include xylazine or preparations, compounds, mixtures, or substances containing xylazine as "adulterant depressants" for the purposes of criminal sale and possession offenses. The bill enhances the criminal penalties for the sale and possession of these substances, which are often used to adulterate other drugs like heroin and fentanyl. The goal of the bill is to address the growing problem of xylazine-related overdoses and its increasing presence in the illegal drug supply.

Committee Categories

Health and Social Services

Sponsors (22)

Last Action

held for consideration in health (on 05/14/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...